MORGAN HAYES: Open Payments
NPI 1790370740 · DILLON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 84 payments from 25 companies in 2025. Trend: 2023 $1,794 · 2024 $1,884 · 2025 $1,501
Food & beverage: $1,501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $156 |
| Lilly USA, LLC | 7 | $128 |
| Merck Sharp & Dohme LLC | 6 | $112 |
| Corcept Therapeutics | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $97 |
| Forte Bio-Pharma LLC | 6 | $95 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| PFIZER INC. | 5 | $87 |
| Amgen Inc. | 5 | $81 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
Products named: VERQUVO, MOUNJARO, Korlym, Kerendia, PROLATE, JARDIANCE, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
